Among them, CD4+ T cell activation has been described by several groups within the first weeks after stroke, but it has remained unknown for how long such activation lasts in patients, which pathways could be of importance for chronic activation, and if such activation also applies for CD8+ T cells. This evidence concerns the gene CD8A and stroke disorder.